Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Developmental Neuroscience
|
May 12, 2005
Mesencephalic trigeminal nucleus development is dependent on Krox-20 expression
Shampa De, Anh Quan Nguyen, Charles F Shuler, et al.
Nature Medicine
|
January 13, 2025
Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates
Robert W Cross, Courtney Woolsey, Abhishek N Prasad, et al.
Science Advances
|
March 14, 2025
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection
Courtney Woolsey, Robert W Cross, Victor C Chu, et al.
Science (New York, N.Y.)
|
March 14, 2024
Oral administration of obeldesivir protects nonhuman primates against <i>Sudan ebolavirus</i>
Robert W Cross, Courtney Woolsey, Victor C Chu, et al.
Journal of Medicinal Chemistry
|
August 19, 2023
Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green Monkeys
Richard L Mackman, Rao V Kalla, Darius Babusis, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential
David R Martinez, Fernando R Moreira, Mark R Zweigart, et al.
Science Translational Medicine
|
May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses
David R Martinez, Fernando R Moreira, Nicholas J Catanzaro, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Developmental Neuroscience
|
May 12, 2005
Mesencephalic trigeminal nucleus development is dependent on Krox-20 expression
Shampa De, Anh Quan Nguyen, Charles F Shuler, et al.
Nature Medicine
|
January 13, 2025
Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates
Robert W Cross, Courtney Woolsey, Abhishek N Prasad, et al.
Science Advances
|
March 14, 2025
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection
Courtney Woolsey, Robert W Cross, Victor C Chu, et al.
Science (New York, N.Y.)
|
March 14, 2024
Oral administration of obeldesivir protects nonhuman primates against <i>Sudan ebolavirus</i>
Robert W Cross, Courtney Woolsey, Victor C Chu, et al.
Journal of Medicinal Chemistry
|
August 19, 2023
Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green Monkeys
Richard L Mackman, Rao V Kalla, Darius Babusis, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential
David R Martinez, Fernando R Moreira, Mark R Zweigart, et al.
Science Translational Medicine
|
May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses
David R Martinez, Fernando R Moreira, Nicholas J Catanzaro, et al.
Page
of 1